Skip to content

Talphera, Inc. TLPH Gross margin

Discontinued — last reported Q3 '22

Gross margin at other companies

Baxter International logo
Baxter InternationalBAX
30.1%-5.9pp
AMP
Amphastar PharmaceuticalsAMPH
47.3%-3.2pp
PTH
Pelthos Therapeutics Inc.PTHS
79.6%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
93.4%+3.7pp
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
86.1%+7.2pp
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
98.4%-0.2pp

Other financials

Income statement

See full
Revenue--100%
Gross profit-$1.9M-52.7%
Operating income-$3.9M-35.4%
Net income-$2.6M+1.4%
EPS (diluted)-$0.10+37.5%

Balance sheet

See full
Cash & equivalents$3.8M-29.0%
Total debt$3.4M-79.7%
Total equity$18.5M+230%
Total assets$30.2M+101%

Cash flow

See full
Operating cash flow-$3.4M+2.0%
CapEx-
Free cash flow-$2.3M+42.9%

Valuation

See full
Market cap$53.46M+493%
P/S53,456.6×+53,123×

Profitability

See full
Operating margin-1,451,600%-1,507,145pp
Net margin-1,425,300%-1,471,200pp
FCF margin-5,116.7%-6,779pp

Returns & leverage

See full
Return on equity-118.4%+15.4pp
Debt / equity0.2×
Current ratio5.3×+2.2×

Where this comes from

Calculated from Talphera, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Talphera, Inc.’s 10-Q, filed November 14, 2022, on SEC EDGAR. View the filing →

Ask your AI about Talphera, Inc.'s gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Talphera, Inc.'s gross margin?
Talphera, Inc. (TLPH) reported gross margin of -127.7% in Q3 2022.
How has Talphera, Inc.'s gross margin changed year-over-year?
Talphera, Inc.'s gross margin decreased by 1612.3% year-over-year, from -7.5% to -127.7%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.